Vasculitis

Behçet Disease Associated With Increased Risk for Psoriasis and Psoriatic Arthritis

Publish Date February 26, 2021

Researchers assessed the association between Behçet disease and psoriasis and psoriatic arthritis, using data from the National Health Insurance Service of Korea.

Avacopan Noninferior to Prednisone for ANCA-Associated Vasculitis

Publish Date February 26, 2021

Avacopan is noninferior, but not superior, to prednisone with respect to remission at week 26 for patients with ANCA-associated vasculitis.

Review: COVID-19 Vasculitis or Novel Vasculitis Mimic?

Publish Date February 11, 2021

In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.

Glucocorticoid Maintenance Therapy Linked to Severe Infectious Complications in ANCA-Associated Vasculitis

Publish Date December 28, 2020

Researchers assessed glucocorticoid maintenance dose and treatment duration on outcomes in patients with ANCA-associated vasculitis.

Avacopan Superior to Standard Therapy in Renal Function in ANCA-Associated Vasculitis

Publish Date November 8, 2020

Study authors evaluated the effect of complement C5a receptor inhibitor avacopan on renal function in ANCA-associated vasculitis.

Hypothyroidism Associated With Different Forms of ANCA-Associated Vasculitis

Publish Date November 7, 2020

Researchers assessed thyroid disease risk between the different forms of ANCA-associated vasculitis (AAV), and compared the clinical features of AAV in patients with and without thyroid disease.

Evaluating Glucocorticoid-Related Damage in Elderly Patients With ANCA-Associated Vasculitis

Publish Date October 28, 2020

In a safety outcome analysis, researchers assessed treatment-related damage in patients with elderly-onset ANCA-associated vasculitis.

Myeloperoxidase ANCA-Associated Vasculitis May Occur After Infection and Regress After Its Resolution

Publish Date October 23, 2020

Researchers performed a systematic review to identify cases of infection-induced antimyeloperoxidase ANCA-associated vasculitis.

Case Study Reports First Known Case of Neutrophilic Arterial Vasculitis in COVID-19

Publish Date October 19, 2020

Authors of this case study reported the first case of neutrophilic arterial vasculitis in COVID-19.

FDA to Review Avacopan for ANCA-Associated Vasculitis

Publish Date September 23, 2020

Avacopan is an orally-administered, small molecule designed to selectively block the complement 5a receptor on destructive inflammatory cells such as blood neutrophils.